|
EFTUD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.604000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.683160E-03 |
| Normal-vs-Stage2 |
2.379000E-04 |
| Normal-vs-Stage3 |
1.961540E-02 |
| Normal-vs-Stage4 |
1.458760E-01 |
| Stage1-vs-Stage2 |
6.567600E-02 |
| Stage1-vs-Stage3 |
5.779200E-01 |
| Stage1-vs-Stage4 |
2.586600E-01 |
| Stage2-vs-Stage3 |
2.600100E-02 |
| Stage2-vs-Stage4 |
1.538060E-02 |
| Stage3-vs-Stage4 |
5.578200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.011700E-04 |
| Normal-vs-AfricanAmerican |
2.603500E-03 |
| Normal-vs-Asian |
1.986300E-02 |
| Caucasian-vs-AfricanAmerican |
4.499200E-01 |
| Caucasian-vs-Asian |
7.367400E-01 |
| AfricanAmerican-vs-Asian |
6.699400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.706400E-02 |
| Normal-vs-Female |
3.155800E-04 |
| Male-vs-Female |
2.755800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.587900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.202900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.049840E-02 |
| Normal-vs-Age(81-100Yrs) |
3.205200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.092600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.382200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.251600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.626400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.422200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.614200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.140000E-01 |
| Classical-VS-Follicular |
6.660200E-03 |
| Classical-VS-Other |
3.464000E-02 |
| Classical-VS-Normal |
1.6601000000005E-05 |
| Tall-VS-Follicular |
4.552800E-01 |
| Tall-VS-Other |
1.365420E-01 |
| Tall-VS-Normal |
1.060040E-01 |
| Follicular-VS-Other |
3.803200E-01 |
| Follicular-VS-Normal |
4.048600E-01 |
| Other-VS-Normal |
3.697600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.280000E-03 |
| Normal-vs-N1 |
8.311000E-01 |
| N0-vs-N1 |
1.733770E-02 |
|
|
